ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1230

The Role of Sleep Problems in Conditioned Pain Modulation in Rheumatoid Arthritis

Yvonne C. Lee1, Bing Lu2, Robert R. Edwards3, Ajay Wasan4, Nicholas Nassikas5, Daniel J. Clauw6, Daniel H. Solomon7 and Elizabeth W. Karlson8, 1Department of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, 2Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 3Anesthesiology, Brigham & Womens Hospital, Chestnut Hill, MA, 4Anesthesiology, Brigham and Women's Hospital, Chestnut Hill, MA, 5Rheumatology, Brigham and Women's Hospital, Boston, MA, 6Anesthesiology/Internal Medicine (Rheum), University of Michigan, Ann Arbor, MI, 7Division of Rheumatology, Brigham and Women's Hospital, Boston, MA, 8Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: pain, rheumatoid arthritis (RA) and sleep

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects II: Clinical Features & Comorbidity/Cardiovascular Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose:   Among rheumatoid arthritis (RA) patients, pain may exist out of proportion to peripheral inflammation.  This observation suggests that central nervous system pain amplification mechanisms, such as diminished conditioned pain modulation (CPM), may play a role in enhancing pain perception among some RA patients.  We examined CPM, pressure pain threshold and pressure pain tolerance among RA patients compared to controls.

Methods: Fifty-eight female RA patients and 54 age-matched controls without chronic pain underwent quantitative sensory testing to assess CPM, pressure pain threshold and pressure pain tolerance.  We induced CPM using a cold water bath, and we assessed pain threshold (when patients first felt pain) and tolerance (when pain was too much to bear) with an algometer.  Associations between RA and quantitative sensory testing measures were analyzed using linear regression models.  Sleep problems, mental health and inflammation were assessed as mediators of the relationship between RA and quantitative sensory testing measures, according to the Baron and Kenny criteria (J Pers Soc Psychol 1986).

Results:   Median CPM levels were 0.5 kg/cm2 (interquartile range (IQR) -0.1, 1.6) among RA patients compared to 1.5 kg/cm2 (IQR -0.1, 2.5) among controls (P = 0.04).  Relative to controls, RA patients had lower pain threshold (P = 0.03) and tolerance (P ≤ 0.004) at the wrists and knees.  Spearman’s correlations between clinical pain scores and quantitative sensory testing measures of pain varied from -0.08 for CPM to -0.31 for wrist tolerance.  Compared to controls, RA patients had greater problems with sleep, catastrophizing, depression and anxiety (P < 0.0001).  Mediation analyses showed significant associations between: 1) RA and CPM (Baron and Kenny criterion #1), 2) RA and sleep problems (Baron and Kenny criterion #2) and 3) sleep problems and CPM, adjusted for RA (Baron and Kenny criterion #3) (Figure 1).  Catastrophizing, depression and anxiety did not mediate the association between RA and CPM.

Conclusion:   RA patients have impaired CPM relative to pain-free controls.  Sleep problems may contribute to low CPM levels.  Future studies are needed to determine whether interventions to improve sleep may improve pain in RA.

 

 

 

 

Figure 1.  A. Unadjusted association between RA and conditioned pain modulation.  B.  Mediation analyses for the role of sleep problems in the association between RA and conditioned pain modulation. The change in β between the unadjusted analyses and the analyses adjusted for sleep problems indicates potential mediation, which is supported by the Baron and Kenny criteria: 1) the significant unadjusted association between RA and conditioned pain modulation, 2) the significant association between RA and sleep problems and 3) the significant association between sleep problems and conditioned pain modulation, adjusted for RA. 

 


Disclosure:

Y. C. Lee,

Forest Laboratories,

2,

Merck Pharmaceuticals,

1,

Novartis Pharmaceutical Corporation,

1,

Elan Corporation,

1;

B. Lu,
None;

R. R. Edwards,
None;

A. Wasan,
None;

N. Nassikas,
None;

D. J. Clauw,

Pfizer Inc, Forest Laboratories, Merck, Nuvo ,

2,

Pfizer, Forest, Lilly, Merck, Nuvo, J and J ,

5;

D. H. Solomon,

Amgen,

2,

Abbott Immunology Pharmaceuticals,

2,

Eli Lilly and Company,

2,

Pfizer Inc,

9;

E. W. Karlson,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-role-of-sleep-problems-in-conditioned-pain-modulation-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology